Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.72 USD | -6.77% | -14.66% | -34.24% |
May. 22 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
May. 22 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.24% | 7.77B | |
+10.47% | 115B | |
+12.18% | 106B | |
-5.88% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.76% | 17.56B | |
-40.50% | 17.32B | |
+6.39% | 14.03B | |
+30.15% | 12.13B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- BMO Capital Adjusts Price Target on Legend Biotech to $90 From $79, Maintains Outperform Rating